Impact of anemia correction on the production of the circulating morphogenetic protein α-Klotho in patients with Stages 3B—4 chronic kidney disease: A new direction of cardionephroprotection
Aim. To investigate the impact of anemia correction with erythropoiesis stimulants on the serum level of the circulating morphogenetic protein α-Klotho in patients with Stages 3B—4 chronic kidney disease (CKD). Subjects and methods. 64 patients aged 42±8 years with Stages 3B—4 nondiabetic CKD were e...
Main Authors: | Yu S Milovanov, N A Mukhin, L V Kozlovskaya, S Yu Milovanova, M M Markina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2016-06-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/viewFile/31977/pdf |
Similar Items
-
Significance of the morphogenetic proteins FGF-23 and Klotho as predictors of prognosis of chronic kidney disease
by: L Iu Milovanova, et al.
Published: (2014-04-01) -
Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease
by: L Yu Milovanova, et al.
Published: (2015-06-01) -
Management of anemia in chronic kidney disease
by: S.V. Kushnirenko
Published: (2021-04-01) -
Serum Klotho in Living Kidney Donors and Kidney Transplant Recipients: A Meta-Analysis
by: Charat Thongprayoon, et al.
Published: (2020-06-01) -
Erythropoiesis-Stimulating Agents in the Management of Anemia in Chronic Kidney Disease or Cancer: A Historical Perspective
by: Matti Aapro, et al.
Published: (2019-01-01)